Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Interventional Study of Effectiveness of Efanesoctocog Alfa Prophylaxis on Synovial Hypertrophy in Patients With Hemophilia A

NCT06941870 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT06941870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06941870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Interventional Study of Effectiveness of Efanesoctocog Alfa Prophylaxis on Synovial Hypertrophy in Patients With Hemophilia A
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Recruiting
Start date
September 23, 2025
Completion date
October 25, 2027
Enrollment
35 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

factor viii deficiency